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Background. We report a case of familial hyperlipidemia in pregnancy that resulted in hemorrhagic pancreatitis. Case. A patient at
27-week gestation was admitted for recurrent pancreatitis secondary to severe hyperlipidemia. With conservative care, the patient
improved but on thefourthday of admissionsheexperienced a sudden onset of hypotension and was diagnosed with hemorrhagic
pancreatitis. Conclusion. Pancreatitis caused by hyperlipidemia is an uncommon event during pregnancy. A familiarity with the
severe complications associated with this potentially life-threatening condition is important.
Copyright © 2009 Karen L. Koscica et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Pancreatitis has been reported to occur in between one in
1000 to one in 12000 deliveries. Gallstone disease accounts
for most cases of pancreatitis during pregnancy. Shock
and sepsis related to pancreatitis result in a relatively high
mortality rate for both the mother and fetus. Most cases
reported to date are mild in nature, although threatening
hemorrhagic crisis may occur [1, 2]. We report on a patient
with a history of familial hyperlipidemia complicated by
acute hemorrhagic pancreatitis
2.Case
A 36-year-old gravida 6, para 3113 presented at 27-week
gestation with abdominal pain. Her history was signiﬁcant
for acute pancreatitis secondary to familial hyperlipidemia
during her ﬁrst pregnancy. She presented in this preg-
nancy with the acute onset of left-sided abdominal pain
and vomiting. On admission, her vital signs included a
blood pressure of 110/70 and a pulse of 86. Her physical
exam was positive for epigastric tenderness on palpation.
Laboratory results revealed a hematocrit of 32.6% and an
otherwise normal complete blood count. Her liver enzymes
were elevated with an amylase of 149U/L (normal 28–
118U/L) and lipase of 136U/L (normal 6–51U/L). She
was admitted for conservative therapy with the diagno-
sis of pancreatitis based on her symptomatology, labora-
tory ﬁndings, and prior history. Her initial management
consisted of intravenous hydration, bowel rest, and pain
management. She was started on insulin due to elevated
blood glucose values. A fasting lipid proﬁle was per-
formed because of her history of familial hyperlipidemia.
Triglyceride level was greatly elevated 2944mg/dl (normal
<150mg/dl).
By hospital day 4 her clinical condition had improved
with a marked decrease in pain and vomiting. The amylase
and lipase were persistently elevated at 265U/L and 218U/L,
respectively. Later that afternoon, she experienced the sud-
den onset of dizziness, lightheadedness, and tachycardia.
Her hematocrit decreased to 18.6%. On physical exam,
there was no abdominal distension or ﬂank bruising. Her
vital signs revealed a blood pressure of 90/60 and a pulse
of 110. Because of the precipitous drop in hematocrit,
she was transferred to the intensive care unit. Consults
with gastroenterology and surgery were obtained. A CT
scan of the abdomen revealed multiple foci of hyperdense
collections adjacent to the pancreas which were interpreted
as consistent with hemorrhagic pancreatitis (see Figure 1).2 Obstetrics and Gynecology International
Figure 1: A CT scan of the abdomen showing hyperdense
area adjacent to the pancreas and consistent with hemorrhagic
pancreatitis.
After a transfusion of 4 units of packed red blood cells, her
hematocrit stabilized at 30%. She was placed on broad spec-
trum antibiotics and total parenteral nutrition. On hospital
day 10, she became febrile and further abnormalities in her
liver function tests were noted. Ultrasound and magnetic
resonance cholangiopancreatography were performed and
revealed no billiary obstruction or psuedocyst formation.
Subsequently, the patient then went into preterm labor,
and delivery was performed due to obstetrical indications.
The fetus was in a breech presentation, and the patient
desired repeat cesarean delivery. Tocolysis was not indicated
because the patient had received previously a course of
antenatal corticosteroids. A live infant with APGAR 8 and
8 and weighing at 1644 grams was delivered by cesarean
section. Upper abdominal ﬁndings during surgery showed
an indurated pancreas and a dilated gall bladder with no
stones palpated. During her postoperative course, she was
diagnosed with sepsis due to a Candida infection associated
with the PICC line. Her jaundice and fever resolved, and she
was discharged on postoperative day 9 after tolerating a low-
fat diet.
3. Comment
Gallstone pancreatitis is still the most common form of
pancreatitis seen during pregnancy. Other disorders that
are associated with pancreatitis during pregnancy include
alcohol abuse, trauma, viral infections, and medications.
Hyperlipidemia is responsible for only a small percentage
of cases that occur during pregnancy [1, 3]. Pregnant
women with pre-existing hyperlipidemia are at higher
risk for pancreatitis due to plasma triglyceride levels
that increase between 2 to 4 folds during pregnancy in
addition to a 50% increase in serum cholesterol. These
changes have been ascribed to the increased estrogen levels
present [1, 4]. As in our patient, triglyceride levels greater
than 2000mg/dl have been reported [1, 3]. A recent
PubMed search using key words pregnancy, hemorrhagic
pancreatitis, and hyperlipidemia revealed only 3 published
cases.
The maternal mortality has been reported to be as high
as 37% by Wilkinson in 1973 but a more recent study
performed at a large public hospital in Dallas, Tex, USA
reported no maternal deaths in 43 cases of pancreatitis
during pregnancy [2, 5]. The perinatal mortality seen with
acute pancreatitis in pregnancy is substantial and has been
estimated at 20%. Most of the adverse perinatal outcomes
are related to prematurity. Termination of pregnancy based
on maternal status is rarely indicated except on a case-
by-case basis, as in this case with acute hemorrhage and
recurrence.
Complications of pancreatitis include psuedocyst, hem-
orrhage, infection, necrosis, shock, and maternal death. As
in our patient, hemorrhagic pancreatitis is a potentially
lethal condition in which the bed of the pancreas undergoes
necrosis and becomes predisposed to bleeding. Blood loss
may be severe and may be associated with a consumptive
coagulopathy.
There is no clear consensus concerning management
of pancreatitis. The mainstay of therapy for pancreatitis
includes intravenous hydration, bowel rest, antimicrobials,
and pain management. Surgery is reserved for recurrent
biliary colic pancreatitis or for the patient who is not
responding to conservative measures [2]. Surgery may also
be chosen if the patient demonstrates any of the severe
complications associated with acute pancreatitis, including
necrosis or hemorrhage. Our patient was stabilized and
recovered with aggressive product replacement and did not
ultimately require surgical intervention.
Severalmedicaltherapieshavebeendescribedforwomen
withpancreatitis.Heparinhasbeenusedtolowertriglyceride
levels. There are reports in the literature in which heparin
therapy for pancreatitis has been seen to be both therapeutic
and safe [4, 6]. Although heparin is an option to control
triglyceride levels, women with acute pancreatitis are at risk
for life threatening hemorrhage within the pancreas, and
therefore heparin could conceivably worsen the ultimate
outcome. Additionally lipid lowering medication or plasma
exchange has also been described in the literature as alterna-
tive therapies [1, 3, 6].
It is important for physicians who care for pregnant
women not only to recognize acute pancreatitis but also
appreciate its complications. Early recognition and prompt
treatment may be life saving.
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